{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:28:50Z","timestamp":1786120130305,"version":"build-2736575974"},"reference-count":55,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.apsb.2026.07.010","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T12:57:54Z","timestamp":1783601874000},"page":"5070-5085","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["H2AC19 promotes lung adenocarcinoma progression via p300\/EGR1\/MMP-1-mediated angiogenesis"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-2646-2101","authenticated-orcid":false,"given":"Fuwen","family":"Zuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2536-3480","authenticated-orcid":false,"given":"Xiaorui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jilong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengzhong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengdong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1155-6170","authenticated-orcid":false,"given":"Ling","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yirong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutao","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2026.07.010_bib1","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.apsb.2026.07.010_bib2","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.apsb.2026.07.010_bib3","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41571-023-00798-3","article-title":"The global burden of lung cancer: current status and future trends","volume":"20","author":"Leiter","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.apsb.2026.07.010_bib4","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1515\/jtim-2024-0019","article-title":"Histological transformation in lung adenocarcinoma: insights of mechanisms and therapeutic windows","volume":"12","author":"Tan","year":"2024","journal-title":"J Transl Int Med"},{"key":"10.1016\/j.apsb.2026.07.010_bib5","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/cac2.12374","article-title":"Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities","volume":"42","author":"Ge","year":"2022","journal-title":"Cancer Commun"},{"key":"10.1016\/j.apsb.2026.07.010_bib6","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41576-024-00759-1","article-title":"Multifunctional histone variants in genome function","volume":"26","author":"Wong","year":"2025","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.apsb.2026.07.010_bib7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrg3673","article-title":"Every amino acid matters: essential contributions of histone variants to mammalian development and disease","volume":"15","author":"Maze","year":"2014","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.apsb.2026.07.010_bib8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrm.2016.166","article-title":"Variants of core histones and their roles in cell fate decisions, development and cancer","volume":"18","author":"Buschbeck","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.apsb.2026.07.010_bib9","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/s41580-020-0262-8","article-title":"The roles of histone variants in fine-tuning chromatin organization and function","volume":"21","author":"Martire","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.apsb.2026.07.010_bib10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41568-020-00330-0","article-title":"Solid tumours hijack the histone variant network","volume":"21","author":"Ghiraldini","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.apsb.2026.07.010_bib11","first-page":"6086","article-title":"Chemotherapy-induced cytokines and prognostic gene signatures vary across breast and colorectal cancer","volume":"11","author":"Groysman","year":"2021","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.apsb.2026.07.010_bib12","article-title":"Claudin18.2 promote gastric cancer proliferation by activating MCM2\/5","volume":"16","author":"Zheng","year":"2026","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2026.07.010_bib13","article-title":"RNAseq analysis of the drug jian-yan-ling (JYL) using both in vivo and in vitro models","volume":"9","author":"Zhang","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.apsb.2026.07.010_bib14","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.ccell.2025.06.012","article-title":"Subclonal immune evasion in non-small cell lung cancer","volume":"43","author":"Dijkstra","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.apsb.2026.07.010_bib15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ccr.2008.01.031","article-title":"The inhibition of tumor cell intravasation and subsequent metastasis via regulation of in vivo tumor cell motility by the tetraspanin CD151","volume":"13","author":"Zijlstra","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.apsb.2026.07.010_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116783","article-title":"Survival strategies: how tumor hypoxia microenvironment orchestrates angiogenesis","volume":"176","author":"Yang","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.apsb.2026.07.010_bib17","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1200\/JCO.1999.17.6.1802","article-title":"Expression and prognostic significance of metalloproteinases and their tissue inhibitors in patients with small-cell lung cancer","volume":"17","author":"Michael","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.apsb.2026.07.010_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ady2104","article-title":"Direct recruitment of TONSOKU by the N-terminal tails of histone variants H2A.X and H2A.W coordinates DNA repair","volume":"11","author":"Li","year":"2025","journal-title":"Sci Adv"},{"key":"10.1016\/j.apsb.2026.07.010_bib19","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.cell.2005.09.038","article-title":"MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks","volume":"123","author":"Stucki","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2026.07.010_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/plphys\/kiaf469","article-title":"H3 acetylation triggers SWR1 recruitment to promote H2A.Z incorporation into chromatin and stimulate gene expression","volume":"199","author":"Jiang","year":"2025","journal-title":"Plant Physiol"},{"key":"10.1016\/j.apsb.2026.07.010_bib21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.cell.2005.08.036","article-title":"Genome-wide dynamics of Htz1, a histone H2A variant that poises repressed\/basal promoters for activation through histone loss","volume":"123","author":"Zhang","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2026.07.010_bib22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.canlet.2013.03.022","article-title":"MacroH2A\u2013an epigenetic regulator of cancer","volume":"336","author":"Cantari\u00f1o","year":"2013","journal-title":"Cancer Lett"},{"key":"10.1016\/j.apsb.2026.07.010_bib23","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/j.molcel.2021.04.015","article-title":"Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300\/CBP inhibition","volume":"81","author":"Hogg","year":"2021","journal-title":"Mol Cell"},{"key":"10.1016\/j.apsb.2026.07.010_bib24","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/s41556-022-00850-x","article-title":"EZH2 noncanonically binds cMyc and p300 through a cryptic transactivation domain to mediate gene activation and promote oncogenesis","volume":"24","author":"Wang","year":"2022","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.apsb.2026.07.010_bib25","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41580-021-00441-y","article-title":"Modulation of cellular processes by histone and non-histone protein acetylation","volume":"23","author":"Shvedunova","year":"2022","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.apsb.2026.07.010_bib26","article-title":"The role of the transcription factor EGR1 in cancer","volume":"11","author":"Wang","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.apsb.2026.07.010_bib27","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/s41418-025-01599-0","article-title":"LINC 02086, a novel biomarker for early detection of gastric cancer and a target for cancer therapy","volume":"33","author":"Sun","year":"2026","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.apsb.2026.07.010_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122489","article-title":"Engineered ionizable lipid nanoparticles mediated efficient siRNA delivery to macrophages for anti-inflammatory treatment of acute liver injury","volume":"631","author":"Zhang","year":"2023","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2026.07.010_bib29","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nrc3627","article-title":"VEGF targets the tumour cell","volume":"13","author":"Goel","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.apsb.2026.07.010_bib30","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.cell.2007.04.019","article-title":"Hypoxia-inducible factors, stem cells, and cancer","volume":"129","author":"Keith","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2026.07.010_bib31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.tips.2012.01.005","article-title":"Hypoxia-inducible factors: mediators of cancer progression and targets for cancer th erapy","volume":"33","author":"Semenza","year":"2012","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.apsb.2026.07.010_bib32","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.3390\/ijms25063144","article-title":"Roles of histone H2A variants in cancer development, prognosis, and treatment","volume":"25","author":"Lai","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.07.010_bib33","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.244749","article-title":"Histone variants at a glance","volume":"134","author":"Talbert","year":"2021","journal-title":"J Cell Sci"},{"key":"10.1016\/j.apsb.2026.07.010_bib34","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.medj.2024.08.010","article-title":"Patient-derived organoids in precision cancer medicine","volume":"5","author":"Tong","year":"2024","journal-title":"Med"},{"key":"10.1016\/j.apsb.2026.07.010_bib35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.actbio.2022.04.050","article-title":"Patient-derived tumour organoids: a bridge between cancer biology and personalised therapy","volume":"146","author":"Wu","year":"2022","journal-title":"Acta Biomater"},{"key":"10.1016\/j.apsb.2026.07.010_bib36","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1172\/JCI6870","article-title":"Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention","volume":"103","author":"Stetler-Stevenson","year":"1999","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2026.07.010_bib37","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0092-8674(00)81768-7","article-title":"Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins","volume":"95","author":"Hiraoka","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2026.07.010_bib38","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.1038\/sj.onc.1204097","article-title":"Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment","volume":"19","author":"Zucker","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.apsb.2026.07.010_bib39","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.matbio.2015.04.004","article-title":"Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature","volume":"44-46","author":"Deryugina","year":"2015","journal-title":"Matrix Biol"},{"key":"10.1016\/j.apsb.2026.07.010_bib40","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41586-018-0621-1","article-title":"Transcription factor dimerization activates the p300 acetyltransferase","volume":"562","author":"Ortega","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.07.010_bib41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov"},{"key":"10.1016\/j.apsb.2026.07.010_bib42","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41573-020-0077-5","article-title":"Targeting the epigenetic regulation of antitumour immunity","volume":"19","author":"Hogg","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2026.07.010_bib43","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","article-title":"Cancer epigenetics: from mechanism to therapy","volume":"150","author":"Dawson","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2026.07.010_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111701","article-title":"Histone modification in NSCLC: molecular mechanisms and therapeutic targets","volume":"22","author":"Bajbouj","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.07.010_bib45","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13045-022-01331-2","article-title":"Super-enhancer hijacking LINC01977 promotes malignancy of early-stage lung adenocarcinoma addicted to the canonical TGF-\u03b2\/SMAD3 pathway","volume":"15","author":"Zhang","year":"2022","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.apsb.2026.07.010_bib46","doi-asserted-by":"crossref","first-page":"29","DOI":"10.25259\/Cytojournal_36_2024","article-title":"From microscopes to molecules: the evolution of prostate cancer diagnostics","volume":"21","author":"Tao","year":"2024","journal-title":"CytoJournal"},{"key":"10.1016\/j.apsb.2026.07.010_bib47","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1200\/JCO.2005.08.127","article-title":"EGR1 predicts PTEN and survival in patients with non-small-cell lung cancer","volume":"23","author":"Ferraro","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.apsb.2026.07.010_bib48","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1182\/blood-2010-08-299784","article-title":"Antiangiogenic antitumor activities of IGFBP-3 are mediated by IGF-independent suppression of Erk1\/2 activation and Egr-1-mediated transcriptional events","volume":"118","author":"Kim","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.apsb.2026.07.010_bib49","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/cr.1998.17","article-title":"Complex role of matrix metalloproteinases in angiogenesis","volume":"8","author":"Sang","year":"1998","journal-title":"Cell Res"},{"key":"10.1016\/j.apsb.2026.07.010_bib50","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/81971","article-title":"Crystal structure of a nucleosome core particle containing the variant histone H2A.Z","volume":"7","author":"Suto","year":"2000","journal-title":"Nat Struct Biol"},{"key":"10.1016\/j.apsb.2026.07.010_bib51","doi-asserted-by":"crossref","first-page":"7675","DOI":"10.1093\/nar\/gky540","article-title":"Histone H2A variants confer specific properties to nucleosomes and impact on chromatin accessibility","volume":"46","author":"Osakabe","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.apsb.2026.07.010_bib52","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41568-024-00736-0","article-title":"Targeting the tumour vasculature: from vessel destruction to promotion","volume":"24","author":"Guelfi","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.apsb.2026.07.010_bib53","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3390\/ijms19041232","article-title":"Resistance to anti-angiogenic therapy in cancer-alterations to anti-VEGF pathway","volume":"19","author":"Itatani","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.07.010_bib54","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0140-6736(15)01088-0","article-title":"Antiangiogenic therapy in oncology: current status and future directions","volume":"388","author":"Jayson","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2026.07.010_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2025.108934","article-title":"Crosstalk between anti-angiogenic and pro-angiogenic pathways in disease: mechanisms and therapeutic strategies","volume":"276","author":"Wang","year":"2025","journal-title":"Pharmacol Ther"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526004478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526004478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:02:24Z","timestamp":1786046544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383526004478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":55,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2211383526004478"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2026.07.010","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"H2AC19 promotes lung adenocarcinoma progression via p300\/EGR1\/MMP-1-mediated angiogenesis","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2026.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}